Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACACB | O00763 | 1/20 | 0.60 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.58 |
| ▸ | CTSS | P25774 | 1/20 | 0.57 |
| ▸ | KAT6A | Q92794 | 4/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | GAA | P10253 | 1/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.54 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.53 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.52 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | PKM | P14618 | 1/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | MEN1 | O00255 | 1/20 | 0.49 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.49 |
| ▸ | TPSAB1 | Q15661 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8428222 | 0.88 | RAPGEF3 (0.54) | ACACBALDH1A1CTSSKAT6ALMNA | |
| SCHEMBL5729430 | 0.87 | ACACB (0.47) | ACACBALDH1A1CTSSKAT6ALMNA | |
| SCHEMBL7663141 | 0.84 | GPR27 (0.59) | ALDH1A1KAT6ALMNAKDM4EMAPT | |
| SCHEMBL28588397 | 0.83 | ALDH1A1 (0.51) | ALDH1A1GAASMN1; SMN2POLBNPSR1 | |
| SCHEMBL10420167 | 0.83 | GAA (0.65) | ALDH1A1CTSSKAT6AGAAPOLB | |
| SCHEMBL14045828 | 0.82 | ALDH1A1 (0.59) | ALDH1A1CTSSKAT6APOLBNPSR1 | |
| SCHEMBL6786683 | 0.82 | ACACB (0.64) | ACACBALDH1A1CTSSKAT6ALMNA | |
| SCHEMBL8318684 | 0.80 | CTSS (0.65) | ALDH1A1CTSSKAT6ALMNAGAA | |
| SCHEMBL9895812 | 0.80 | ACACB (0.61) | ACACBALDH1A1KAT6ALMNAGAA | |
| SCHEMBL7244008 | 0.80 | MEP1B (0.59) | ALDH1A1GAASMN1; SMN2POLBKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6127340-A | ESPCECIALLY THROMBIN, IN WHICH THE P1-P2 NATURAL AMIDE LINKAGE IS REPLACED BY ANOTHER BOND; INHIBITING COAGULATION OF BLOOD IN A CONTAINER; TREATMENT OR PREVENTION OF THROMBOSIS | TRIGEN LIMITED (GB) | 2000-10-03 | — | — | US | disclosed |
| US-5763436-A | ANTICOAGULANTS | HOFFMANN-LA ROCHE INC. (US) | 1998-06-09 | — | — | US | disclosed |
| EP-0809650-A1 | SERINE PROTEASE INHIBITORS | ELLERMAN PHARMACEUTICALS LIMITED (GB) | 1997-12-03 | — | — | EP | disclosed |
| US-5595999-A | ANTICOAGULANTS | HOFFMANN-LA ROCHE INC. (US) | 1997-01-21 | — | — | US | disclosed |
| US-5583133-A | ANTICOAGULANTS | HOFFMANN-LA ROCHE INC. (US) | 1996-12-10 | — | — | US | disclosed |
| WO-1996025427-A1 | SERINE PROTEASE INHIBITORS | ELLERMAN PHARMACEUTICALS LIMITED (GB) | 1996-08-22 | — | — | WO | disclosed |
| US-5532232-A | INHIBIT THROMBIN INDUCED PLATELET AGGREGATION; FIBRINOGEN ANTICOAGULANTS IN BLOOD | HOFFMANN-LA ROCHE INC. (US) | 1996-07-02 | — | — | US | disclosed |
| US-5393760-A | Cardiovascular disorders, antitumor agents | HOFFMANN-LA ROCHE INC. (US) | 1995-02-28 | — | — | US | disclosed |
| EP-0468231-B1 | Guanidins | HOFFMANN LA ROCHE (CH) | 1994-09-21 | — | — | EP | disclosed |
| US-5260307-A | Inhibit thrombin-induced platlet aggregation and clotting of fibrogen in plasma | HOFMANN-LA ROCHE INC. (US) | 1993-11-09 | — | — | US | disclosed |
| EP-0468231-A2 | Guanidins | F. HOFFMANN-LA ROCHE AG (CH) | 1992-01-29 | — | — | EP | disclosed |